Bellerophon Therapeutics Inc
(BLPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,237 | -2,316 | 2,822 | -19,831 | -14,815 |
| Depreciation Amortization | 2 | 2 | 1 | 65 | 61 |
| Other Working Capital | -4,030 | 262 | 179 | 1,211 | 712 |
| Other Operating Activity | 278 | 397 | 264 | 785 | 624 |
| Operating Cash Flow | $-7,987 | $-1,655 | $3,266 | $-17,770 | $-13,418 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 140 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $140 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,010 | 5,010 | 4,982 | N/A | N/A |
| Other Financing Activity | -2 | -2 | 0 | -40 | 0 |
| Financing Cash Flow | $5,008 | $5,008 | $4,982 | $-40 | $N/A |
| Beginning Cash Position | 7,329 | 7,329 | 7,329 | 25,139 | 25,139 |
| End Cash Position | 4,490 | 10,682 | 15,577 | 7,329 | 11,721 |
| Net Cash Flow | $-2,839 | $3,353 | $8,248 | $-17,810 | $-13,418 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,987 | -1,655 | 3,266 | -17,770 | -13,418 |
| Free Cash Flow | -7,987 | -1,655 | 3,266 | -17,770 | -13,418 |